Complete dataset included in the full report. Detailed tables, regional splits, forecasts, and methodologies are available with purchase.

Pitocin is a prescription injectable medication containing oxytocin, used to induce or strengthen labor by stimulating uterine contractions. It is administered intravenously and manufactured by Endo USA, Inc. This information was generated using AI and is provided for informational and research purposes only.

The oxytocin market was valued at $1.52 billion in 2025 and is projected to reach $2.54 billion by 2034, growing at 5.8% CAGR.

Corpus-verified analysis of 299 PubMed studies on Oxytocin. Includes evidence scores, target interactions, pathway associations, and research domain classification.

Aggregated anonymized self-reports from PeptIQ users tracking Oxytocin.

Daily median research-vendor price per milligram for Oxytocin, aggregated across a minimum of 5 distinct vendors per day (5 days of history, 29 vendors currently tracked). Winsorized at p5/p95, mg-normalized.

925 registered clinical trial record(s) for Oxytocin, a nonapeptide hormone, reproduced from public registers with the date each was retrieved.

A collection of 56 brain maps. Each brain map is a 3D array of values representing properties of the brain at different locations.

Collection description

This collection includes unthresholded maps for all the analyses conducted in the study. Only the conjunction maps are presented thresholded at voxel level p=0.002.

Aggregated, self-reported Oxytocin doses, side-effect frequencies, and outcomes from pseudonymous PepTalk contributors. Unverified, educational only.

Oxytocin Supplement Market size, share, and trend analysis indicates growth from USD 351 Million in 2025 to USD 895 Million by 2035, at a CAGR of 9.8%

This is an unblinded, sequential study of subjects; all participants will receive an infusion of oxytocin and intranasal administration of oxytocin with blood samples taken thereafter in order to create a formula to describe the concentrations of oxytocin in the blood over time (pharmacokinetics). In this study healthy volunteers. Participants will come to the Clinical Research Unit (CRU) on study day 1 and have two IVs inserted; one in each arm. Participants will get a 30 minute infusion through one of the IV catheters of oxytocin and blood will be taken several times over the next 120 minutes, plasma separated, and the amount of oxytocin measured in the plasma samples. Participants will come to the CRU on study day 2 and have one IV inserted; in the arm. Participants will self administer intranasal oxytocin and blood will be taken several times over the next 60 minutes and the amount of oxytocin measured in the plasma samples. This information will be analyzed by another group at Stanford University under a data sharing agreement between the institutions and funded by a grant from the National Institutes of Health. Compartmental modeling will be performed using NONMEM to describe the change in oxytocin concentrations over time. The effect of subject age, sex, race, ethnicity and weight on the pharmacokinetics of oxytocin will be examined, since these factors can affect pharmacokinetics and are important to better adjust the dose of drug to the individual. The main purpose of this study is to determine the amount of oxytocin in plasma after IV and i.n. administration. The research participants will not benefit from this study, but the knowledge investigators get will be important to adjust oxytocin dose to individuals, and to be able to calculate plasma oxytocin concentrations after various doses in the future. The sample size chosen is needed to get an accurate estimate for the parameters in the pharmacokinetic model for the population, not just the subjects in this study.

Social acceptance (vs. rejection) is assumed to have widespread positive effects on the recipient; however, ethnic/racial minorities often react negatively to social acceptance by White individuals. One possibility for such reactions might be their lack of trust in the genuineness of White individuals’ positive evaluations. Here, we examined the role that oxytocin—a neuropeptide putatively linked to social processes—plays in modulating reactions to acceptance or rejection during interracial interactions. Black participants (N = 103) received intranasal oxytocin or placebo and interacted with a White, same-sex stranger who provided positive or negative social feedback. After positive feedback, participants given oxytocin (vs. placebo) tended to display approach-oriented cardiovascular responses of challenge (vs. threat), exhibited more cooperative behavior, and perceived the partner to have more favorable attitudes toward them after the interaction. Following negative feedback, oxytocin reduced anger suppression. Oxytocin did not modulate testosterone reactivity directly, but our exploratory analysis showed that the less participants suppressed anger during the interaction with their partner, the greater testosterone reactivity they displayed after the interaction. These results survived the correction for multiple testing with a false discovery rate (FDR) of 20%, but not with a rate of 10 or 5%. Discussion centers on the interplay between oxytocin and social context in shaping interracial interactions.

According to Market Research Intellect, the Injection Oxytocin Market stood at USD 1.28 Billion in 2025 and is forecast to reach USD 2.53 Billion by 2035, progressing at a CAGR of 7.0%.

This pathway shows a high-level overview of oxytocin signalling.

Access verified Oxytocin import shipments data with buyer and supplier. Analyze real-time Oxytocin import trade activity with Eximpedia.

A collection of 5 brain maps. Each brain map is a 3D array of values representing properties of the brain at different locations.

Collection description

Randomized, double-blind, placebo-controlled, cross-over design to compare the impacts of a single intranasal oxytocin dose on amygdala connectivity among individuals with schizophrenia (n = 22) versus healthy controls (n = 24).

Oxytocin Market size, share, and trend analysis indicates growth from USD 1.3 Billion in 2025 to USD 2.94 Billion by 2035, at a CAGR of 8.5%

This dataset supports the publication "The neural distribution of vasotocin, oxytocin, dopamine and serotonin in two Australian skinks with contrasting social lives ". The dataset comprises scanned microscope slides from which data for this paper was collected. We also include supplementary data tables detailing the distribution of vasotocin, oxytocin, dopamine and serotonin in other lizard species studied to date:

Abstract

The neurotransmitters vasotocin, oxytocin, dopamine, and serotonin are widely involved in vertebrate social behaviour, and changes in their abundance and distribution in the brain have been linked to the evolution of complex sociality. Reptiles provide an excellent system in which to investigate the neural mechanisms of social living. Using immunohistochemistry, we compare distributions of these transmitters in two skinks differing primarily in social ecology: the family-living Liopholis whitii and the solitary Eulpamrus quoyii. We describe patterns of immunopositive signal for both cell bodies and fibres across the entire brain (excluding the olfactory bulbs). In both species, vasotocin and oxytocin were found in the preoptic area, paraventricular nucleus, supraoptic nucleus, dorsomedial hypothalamus and supraoptic decussation, as well as surrounding the lateral forebrain bundle. Tyrosine hydroxylase (a marker for dopamine) was found in the paraventricular organ nucleus, substantia nigra and ventral tegmental area, and serotonin was found in the raphe nuclei and superior reticular field. We found novel oxytocin cell groups in the dorsomedial hypothalamus and cerebellum of L. whitii, and novel serotonin signal in the red nucleus of E. quoyii. Immunopositive signals found only in L. whitii also include vasotocin in the ventral tegmental area, tyrosine hydroxylase in the interpeduncular nucleus, and serotonin in the suprachiasmatic nucleus. The qualitatively greater abundance of these transmitters in the family-living L. whitii suggests that these molecules may have played an important role in the evolution of social behaviour in these skinks and provides a foundation for broader comparisons across the social skinks.

The implementation of an institutional oxytocin checklist did not affect expert assessment of the use of oxytocin in labor. Checklist is included within the publication's appendix.

SPM{T_[237.0]} - contrast 1: PE_plac_self

Collection description

This collection contains fMRI data from a study in which healthy males received L-DOPA (100 mg + 25 mg carbidopa), intranasal oxytocin (24 IU), or placebo using a double-blind placebo-controlled cross-over design. In each session, participants performed a probabilistic reinforcement learning task with potential rewards for themselves, an anonymous other participant, or no one, during functional magnetic resonance imaging. Computational models of reinforcement learning were used to calculate prediction errors (PEs) and learning rates. Contrasts involve the factors drug (L-DOPA, oxytocin, placebo) and recipient (self, other, no one).

(Note that paper links to https://identifiers.org/neurovault.collection:13141, but this collection was accidentally deleted.)

Subject species

homo sapiens

Modality

fMRI-BOLD

Analysis level

group

Cognitive paradigm (task)

Probabilistic Selection Task

Map type

T